Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Evaluation of Nepafenac Ophthalmic Suspension, 0.3% Compared to Nepafenac Ophthalmic Suspension 0.1% and Vehicle for Prevention and Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery

NCT01318499 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT01318499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01318499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Evaluation of Nepafenac Ophthalmic Suspension, 0.3% Compared to Nepafenac Ophthalmic Suspension 0.1% and Vehicle for Prevention and Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery
Lead sponsor
Alcon Research
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2011
Completion date
September 30, 2011
Enrollment
1,342 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract